Paper39239161
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea.
Charles F and 6 others. Public Health Action, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Papers, record 39239161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31580333 | The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017. | Public Health Action | 2019 | https://conductscience.org/library/papers/31580333 | PubMed |
| 2 | 35524232 | Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/35524232 | PubMed |
| 3 | 31579651 | Challenges in TB diagnosis and treatment: the Kavieng Provincial Hospital experience, Papua New Guinea. | Public Health Action | 2019 | https://conductscience.org/library/papers/31579651 | PubMed |
| 4 | 30332452 | Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013. | PLoS One | 2018 | https://conductscience.org/library/papers/30332452 | PubMed |
| 5 | 34097769 | Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34097769 | PubMed |
| 6 | 36883701 | Beyond patient delay, navigating structural health system barriers to timely care and treatment in a high burden TB setting in Papua New Guinea. | Glob Public Health | 2023 | https://conductscience.org/library/papers/36883701 | PubMed |
| 7 | 29562985 | Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment? | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29562985 | PubMed |
| 8 | 30057853 | Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008-2016. | Western Pac Surveill Response J | 2018 | https://conductscience.org/library/papers/30057853 | PubMed |
| 9 | 36962674 | Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014-2021. | PLOS Glob Public Health | 2022 | https://conductscience.org/library/papers/36962674 | PubMed |
| 10 | 31579645 | Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea. | Public Health Action | 2019 | https://conductscience.org/library/papers/31579645 | PubMed |
| 11 | 36048756 | Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens. | Emerg Infect Dis | 2022 | https://conductscience.org/library/papers/36048756 | PubMed |
| 12 | 27003160 | The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey. | PLoS One | 2016 | https://conductscience.org/library/papers/27003160 | PubMed |
| 13 | 26393097 | Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia. | Public Health Action | 2014 | https://conductscience.org/library/papers/26393097 | PubMed |
| 14 | 24623906 | Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. | Bull World Health Organ | 2014 | https://conductscience.org/library/papers/24623906 | PubMed |
| 15 | 31579644 | Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017. | Public Health Action | 2019 | https://conductscience.org/library/papers/31579644 | PubMed |
| 16 | 33735231 | Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis. | PLoS One | 2021 | https://conductscience.org/library/papers/33735231 | PubMed |
| 17 | 35039860 | Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data. | J Infect Dis | 2022 | https://conductscience.org/library/papers/35039860 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42643644 | Genomic epidemiology of the Mycobacterium tuberculosis complex in Fiji reveals community transmission and human Mycobacterium bovis infection. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42643644 | PubMed |
| 39239155 | Operational research highlights ongoing challenges for comprehensive TB services in Papua New Guinea. | Public Health Action | 2024 | https://conductscience.org/library/papers/39239155 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39239161
GET https://conductscience.org/api/papers/v1/39239161/authors